1,397
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Novel thiadiazole-thiazole hybrids: synthesis, molecular docking, and cytotoxicity evaluation against liver cancer cell lines

, , , ORCID Icon, , & ORCID Icon show all
Pages 1005-1015 | Received 23 Aug 2022, Accepted 10 Oct 2022, Published online: 21 Oct 2022

References

  • Gomes JPM, Cardoso CRP, Varanda EA, et al. Mutagenic and (anti)estrogenicactivities of tingenone and pristimerin. Rev Bras Farmacogn. 2011;21:963–971.
  • Ioannou GN, Splan MF, Weiss NS, et al. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroent Hepatol. 2007;5:938–945.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  • Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Nat Cancer Inst. 2017;109. doi:10.1093/jnci/djx030
  • Sujatha K, Vedula RR. Novel one-pot expeditious synthesis of 2,4-disubstituted thiazoles through a three-component reaction under solvent free conditions. Synth Commun. 2018;48:302–308.
  • Gomha SM, Abdelhady HA, Hassain DZH, et al. Thiazole based thiosemicarbazones: synthesis, cytotoxicity evaluation and molecular docking study. Drug Design Development and Therapy. 2021;15:659–677.
  • Alshabanah LA, Al-Mutabagani LA, Gomha SM, et al. Three-component synthesis of some new coumarin derivatives as anti-cancer agents. Front Chem. 2022;9:762248.
  • Mahmoud HK, Sayed AR, Abdel-Aziz MM, et al. Synthesis of new thiazole clubbed imidazo[2,1-b]thiazole hybrid as antimycobacterial agents. Med Chem. 2022;18:1100–1108.
  • Nayak S, Gaonkar S L. A review on recent synthetic strategies and pharmacological importance of 1,3-thiazole derivatives. Mini Rev Med Chem. 2019;19:215–238.
  • Kumar S, Aggarwal R. Thiazole: A privileged motif in marine natural products. Mini Rev Org Chem. 2019;16:26–34.
  • Sayed AR, Elsawy H, Shaaban S, et al. Design, synthesis, and biological evaluations of novel az-othiazoles based on thioamide. Curr Issues Mol Biol. 2022;44:2956–2966.
  • Morigi R, Locatelli A, Leoni A, et al. Recent patents on thiazole derivatives endowed with antitumor activity. Recent Pat Anticancer Drug Discov. 2015;10:280–297.
  • Fuqiang LIU, Palmer DC, Sorgi KL. Diethoxyphosphinyl acetic acid hydrazide: a uniquely versatile reagent for the preparation of fused [5,5]-, [5,6]-, and [5,7]-3-[(E)-2-(arylvinyl)]-1,2,4-triazoles. Tetrahedron Lett 2004;45:1877–1880.
  • Danilenko GI, Rubalko SL, Maksimov YN, et al. Adamantane-1- and norbornane-2-carboxylic acid hydrazides as HIV inhibitors. Pharmaceut Chem J. 2000;34:23–24.
  • Constable DJC, Curzons AD, Cunningham VL. Metrics to ‘green’ chemistry-which Are the best? Green Chem. 2002;4:521–527.
  • Saha A, Kumar R, Kumar R, et al. Development and assessment of green synthesis of hydrazides. Indian J Chem. 2010;49B:526–531.
  • Kushwaha N, Kushwaha SKS, Rai AK. Biological activities of thiadiazole derivatives: A review. Inter J Chem Res. 2012;4:517–531.
  • Singh AK, Mishra G, Jyoti K. Review on biological activities of 1,3,4-thiadiazole derivatives. J App Pharm Sci. 2011;1:44–49.
  • Siddiqui N, Ahuja P, Ahsan W, et al. Thiadiazole: progress report on biological activities. J Chem Pharm Res. 2009;1:19–30.
  • Gomha SM, Riyadh SM, Huwaimel B, et al. Synthesis, molecular docking study and cytotoxic activity on mcf cells of some new thiazole clubbed thiophene scaffolds. Molecules. 2022;27:4639.
  • Gomha SM, Abdel-Aziz HA. Enaminones as building blocks in heterocyclic preparations: synthesis of novel pyrazoles, pyrazolo[3,4-d]pyridazines, pyrazolo[1,5-a]pyrimidines, pyrido[2,3-d]pyrimidines linked to imidazo[2,1-b]thiazole system. Heterocycles. 2012;85:2291–2303.
  • Abbas IM, Riyadh SM, Abdallah MA, et al. A novel route to tetracyclic fused tetrazines and thiadiazines. J Heterocycl Chem. 2006;43:935–942.
  • Said MA, Riyadh SM, Al-Kaff NS, et al. Synthesis and greener pastures biological study of bis-thiadiazoles as potential COVID-19 drug candidates. Arabian J Chem. 2022;15:104101.
  • Eldebss TMA, Gomha SM, Abdulla MM, et al. Novel pyrrole derivatives as selective CHK1 inhibitors: design, regioselective synthesis and molecular modeling. Med Chem Com. 2015;6:977–987.
  • Gomha SM, Edrees MM, Muhammad ZA, et al. 5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in-vitro cytotoxicity evaluation as potential anticancer agents. Drug Design Development and Therapy. 2018;12:1511–1523.
  • Makam P, Kankanala R, Amresh P, et al. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies. Eur J Med Chem. 2013;69:564–576.
  • Al-Humaidi JY, Badrey MG, Aly AA, et al. Evaluation of the binding relationship of the RdRp enzyme to novel thiazole/ acid hydrazone hybrids obtainable through green synthetic procedure. Polymer. 2022;14(15):3160.
  • Abdelhamid AO, Zohdi HF, Rateb NM. Reactions with hydrazonoyl halides XXI: reinvestigation of the reactions of hydrazonoyl bromides with 1,1-dicyanothio-acetanilide. J Chem Res. (S). 1998;3:184–185.
  • Qiu XL, Li G, Wu G, et al. Synthesis and biological evaluation of a series of novel inhibitor of Nek2/Hec1 analogues. J Med Chem. 2009;52:1757–1767.
  • Tsoua H, MacEwan G, Birnberg G, et al. Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl) methylene-4-hydroxybenzofuran- 3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). Bioorg Med Chem Lett. 2010;20:2321–2325.
  • Mavrova AT, Wesselinova D, Tsenov YA, et al. Synthesis, cytotoxicity and effects of some1,2,4-triazole and 1,3,4-thiadiazole derivatives on immunocompetent cells. Eur J Med Chem. 2009;44:63–69.
  • Oleson JJ, Slobada A, Troy WP, et al. The carcinostatic activity of some 2-amino-1,3,4-thiadiazoles. J Am Chem Soc. 1955;77:6713–6714.
  • Matysiak J, Opolski A. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Bioorg Med Chem. 2006;14:4483–4489.
  • Kaminskyy D, Kryshchyshyn A, Nektegayev I, et al. Isothiocoumarin-3-carboxylic acid derivatives: synthesis, anticancer and antitrypanosomal activity evaluation. Eur J Med Chem. 2014;75:57–66.
  • Popsavin M, Spaić S, Svirčev M, et al. Synthesis and in vitro antitumour screening of 2-(β-d-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic. Bioorg Med Chem Lett. 2012;22:6700–6704.
  • Janda E, Nepveu F, Calamini B, et al. Molecular pharmacology of NRH:quinone oxidoreductase 2: A- detoxifying enzyme acting as an undercover toxifying enzyme. Molecular Pharmacol. 2020;98:620–633.
  • Middleton MR, Knox R, Cattell E, et al. Quinone oxidoreductase-2-mediated prodrug cancer therapy. Sci Translational Med. 2010;2:40–50.
  • Leung KKK, Shilton BH. Binding of DNA-intercalating agents to oxidized and reduced quinone reductase 2. Biochem. 2015;54:7438–7448.
  • RCSB PDB - 4ZVM: Oxidized quinone reductase 2 in complex with doxorubicin [Internet]. [cited 2022 Jun 21]. Available from: https://www.rcsb.org/structure/4ZVM
  • Schrödinger Release 2021-4: Glide, Schrödinger, LLC, New York, NY. New York, NY: Schrödinger, LLC.; 2021.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
  • Gomha SM, Riyadh SM, Mahmoud EA, et al. Synthesis and anticancer activities of thiazoles, 1,3-thiazines, and thiazolidine using chitosan-grafted-poly(vinylpyridine) as basic catalyst. Heterocycles. 2015;91:1227–1243.
  • Schrödinger Release 2021-4: LigPrep, Schrödinger, LLC, New York, NY. New York, NY; 2021.
  • Schrödinger Release 2021-4: Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2021; Impact, Schrödinger, LLC, New York, NY; Prime, Schrödinger, LLC, New York, NY. 2021.